Product Center
Promoting the healthy development of the medical testing and diagnostic industry
No data
No data
Complement Factor H Detection Kit (Colloidal Gold )
Target Group
Individuals with painless hematuria, frequent urination, a family history of bladder cancer, smoking, or long-term exposure to industrial chemicals.
Related knowledge
Bladder Cancer
Bladder cancer refers to malignant tumors occurring in the bladder mucosa, the most common malignant tumor in the urinary system. Most patients experience painless visible hematuria in the early stages, while some may have symptoms such as urgency, frequency, and pain during urination.
Cystoscopy is the "gold standard" for bladder cancer diagnosis, but it is invasive and has low patient compliance. Detecting complement factor H in urine has good diagnostic value for early bladder cancer, significantly improving treatment outcomes and quality of life.
Operation Procedure
Pen-Type Operation Method:
Take out the test pen and remove the cap.
Hold the test pen and expose it to urine for 3-5 seconds.
Lay the test pen flat and observe the results within 5-10 minutes.
Card-Type Operation Method:
Collect half a cup of urine using a disposable urine cup.
Use a dropper to draw urine and add 2-3 drops to the sample well.
Let it sit for 5-10 minutes and observe the results.
Product Features
Urine collection for testing, offering convenience, non-invasiveness, and painlessness. High sensitivity, enabling early detection of bladder cancer and changing life trajectories. Simple operation with rapid detection, providing results within 5-10 minutes.
|
Solution
Service Hotline:
AVE Medical Technology Park,No.26 Fuling Road,Xueshi Street,Yuelu District, 410208 Changsha, Hunan , China